Bragar Eagle & Squire, PC is reminding investors of this class action lawsuit

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits have been initiated on behalf of Centessa Pharmaceuticals Plc shareholders CNTA and PayPal Holdings, Inc. PYPL. Shareholders have until the deadlines below to petition the court to appear […]

Bragar Eagle & Squire, PC examines compass,

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP), EyePoint Pharmaceuticals, Inc (NASDAQ: EYPT), Q45 Training Holdings, Inc. (NYSE: FXLV) and PROG Holdings, Inc. (NYSE: PRG). Our investigations address whether these companies have […]

Bragar Eagle & Squire, PC reminds investors of this class

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits have been filed on behalf of Centessa Pharmaceuticals Plc (NASDAQ: CNTA) shareholders. and PayPal Holdings, Inc. (NASDAQ:PYPL). Shareholders have until the deadlines below to petition the court to […]

Bragar Eagle & Squire, PC examines Compass, EyePoint, F45,

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. CMPEyePoint Pharmaceuticals, Inc. EYPTF45 Training Holdings, Inc. FXLVand PROG Holdings, Inc. PRG. Our investigations address whether these companies have violated federal securities laws and/or engaged in […]

The Pomerantz law firm is investigating claims

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI). Those investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, extension 7980. The investigation concerns whether Spectrum and certain of its officers and/or directors have […]

The Pomerantz law firm is investigating claims

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (NYSE: AMPE). Those investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, extension 7980. The investigation concerns whether Ampio and certain of its officers and/or directors have […]

SHAREHOLDER WARNING: Pomerantz Law Firm Reminds Losing Shareholders

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Humanigen, Inc. (“Humanigen” or the “Company”). HGEN and some of his officers. The class action, filed in the United States District Court for the District of New Jersey and Registered at 22-cv-05258, is being brought […]

Bronstein, Gewirtz & Grossman, LLC, a leader, is notifying Centessa

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is notifying investors that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (“Centessa” or the “Company”) CNTA and certain of its officers on behalf of all persons and entities who have purchased or otherwise acquired: (a) […]

Bronstein, Gewirtz & Grossman, LLC, a top firm, announces

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is notifying investors that a class action lawsuit has been filed against Centessa Pharmaceuticals plc (“Centessa” or the “Company”) ( NASDAQ: CNTA) and certain of its officers on behalf of all persons and entities who have purchased or otherwise […]

CLASS ACTION UPDATE for AMPE, DDL and PLTR: Levi & Korsinsky, LLP

NEW YORK, NY / ACCESSWIRE / October 5, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have been filed on behalf of the shareholders of the following public companies. Shareholders interested in serving as lead plaintiffs have until the listed time limits to file a motion with the court. See the links […]